November 8, 2021 – OraSure Technologies, Inc. (Bethlehem, PA) announced the appointment Nancy J. Gagliano, M.D., and Anne C. Whitaker to the company’s board of directors, effective November 8, 2021.
Dr. Gagliano will serve as a Class III Director with an initial term expiring at the company’s 2024 Annual Meeting of Stockholders. She will also serve on the Nominating and Corporate Governance Committee of the board. Dr. Gagliano has over 35 years of experience as a senior healthcare physician executive and practicing physician in internal medicine. Dr. Gagliano most recently served as an executive leader of the National Institute of Health’s RADx Tech, Rapid Acceleration of Diagnostics program. In this position she has helped oversee over one billion dollars of sponsored programs to bring millions of new COVID-19 tests to market. Prior to her work for the National Institute of Health, Dr. Gagliano was the Chief Medical Officer of Culbert Healthcare Solutions, providing strategic guidance on healthcare consulting services.
Whitaker will serve as a Class II Director with an initial term expiring at the company’s 2023 Annual Meeting of Stockholders. She will also serve on the Audit Committee of the board. Whitaker is a seasoned healthcare executive and director with more than 30 years of experience with a proven track record as an executive of building and leading high-performance teams. Whitaker currently serves as Managing Partner of Anne Whitaker Group, LLC, a board and private equity advisory firm, and is the current chairperson of the board of Aerami Therapeutics, a private life science company. Prior to taking the Chair role at Aerami, Anne served as the CEO from October 2018 to November 2020 and as a director from July 2018.